Showing results (1161-1170 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|October 31, 2019
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial IntelligenceAziz Nazha, Mikkael A Sekeres, Rafael Bejar, et al.
JCO Precision Oncology|February 15, 2019
Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in CholangiocarcinomaJan B Egan, David L Marks, Tara L Hogenson, et al.
JCO Precision Oncology|June 17, 2025
Functional Characterization of Variants of Unknown Significance of Fibroblast Growth Factor Receptors 1-4 and Comparison With AI Model-Based PredictionMartin Ziegler, Nadira Khoury, Louisa Maxine Hommerich, et al.
JCO Precision Oncology|May 29, 2025
Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade OsteosarcomaRoelof van Ewijk, Laura S Hiemcke-Jiwa, Jayne Y Hehir-Kwa, et al.
JCO Precision Oncology|June 20, 2025
Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni SyndromeJennie Vagher, Anna Zakas, Lauren Donovan, et al.
JCO Precision Oncology|June 20, 2025
Molecular Correlates of Long-Term Response to Bevacizumab in GlioblastomaJohn L Villano, Catherine R Garcia, Rachael M Morgan, et al.
JCO Precision Oncology|June 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 TrialDenise M Wolf, Christina Yau, Michael Campbell, et al.
JCO Precision Oncology|June 6, 2025
Precision Treatment of Patients With GI Cancer Using Pre-emptive DPYD Genotyping/Phenotyping Plus Pharmacokinetic-Guided Dosing of 5-FluorouracilHelle-Brit Fiebrich-Westra, Christina Haroun, Remco van der Galiën, et al.
JCO Precision Oncology|June 6, 2025
Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell CarcinomaSteven M Monda, Srinivas Nallandhighal, Ulka Vaishampayan, et al.
JCO Precision Oncology|June 4, 2025
Hypoxic Gene Expression Signature as a Predictor of Recurrence and Mortality in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation TherapyNicholas J Eustace, Nikhil T Sebastian, Amy Webb, et al.
Pageof 140